Location · Mesquite, TX
Clinical trials in Mesquite, TX
36 recruiting studies have a site in Mesquite, and 4 of them accept healthy volunteers.
36 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Crystalys Therapeutics
- Location
- Mesquite, TX + 40 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Janssen Research & Development, LLC
- Location
- Mesquite, TX + 37 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
Arrowhead Pharmaceuticals
- Location
- Mesquite, TX + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
AstraZeneca
- Location
- Mesquite, TX + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Corxel Pharmaceuticals
- Location
- Mesquite, TX + 32 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Takeda
- Location
- Mesquite, TX + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Mesquite, TX + 54 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Artiva Biotherapeutics, Inc.
- Location
- Mesquite, TX + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Mesquite, TX + 37 other US sites
- Eligibility basics
- Ages 40–75
- RecruitingPhase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
UCB Biopharma SRL
- Location
- Mesquite, TX + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Zucara Therapeutics Inc.
- Location
- Mesquite, TX + 36 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
ConsideRAte Study - Splenic Stimulation for RA
Galvani Bioelectronics
- Location
- Mesquite, TX + 9 other US sites
- Eligibility basics
- Ages 22–75